内观疗法联合认知行为团体治疗对抑郁症临床疗效的影响

The influence of Naikan therapy plus cognitive-behavior group therapy on therapeutic effectiveness of depression

目的探讨内观疗法联合认知行为团体治疗对抑郁症患者临床疗效的影响。方法将64例抑郁症患者随机分为两组，每组32例。两组均给予舍曲林治疗，研究组在此基础上联合内观治疗及认知行为团体治疗。观察8周。于治疗前及治疗8周末，采用汉密顿焦虑量表、汉密顿抑郁量表及自动想法问卷对两组患者进行测评。治疗8周末，采用团体治疗疗效因子问卷评估疗效因子。结果治疗8周末两组汉密顿焦虑量表、汉密顿抑郁量表及自动想法问卷评分均较治疗前显著下降（P〈0．01），研究组显著低于对照组（P〈0．05或0．01），研究组团体治疗疗效因子中普同性、情绪宣泄、人际学习（获取）、人际学习（付出）、团体凝聚力因子分显著高于对照组（P〈0．01）。结论内观疗法联合认知行为团体治疗可有效缓解或消除住院抑郁症患者的焦虑抑郁情绪，降低负性自动想法的频度，临床疗效显著优于单用药物治疗。

Objective To explore the influence of Naikan therapy plus cognitive-behavior group therapy on therapeutic effectiveness of depression. Methods Sixty-four patients with depression were randomly assigned to two groups of 32 ones each. Both groups received sertraline treatment, research group was plus Naikan therapy and cognitive-behavior group therapy for 8 weeks. Assessments were conducted with the Hamilton Anxiety Scale （HAMA）, Hamilton Depression Scale （HAMD） and Automatic Thoughts Questionnaire （ATQ） at baseline and the end of the 8^th week. Effect factors were assessed with the Group Therapeutic Factors Questionnaire （GTFQ） at the end of the 8^th week. Results At the end of the 8^th week, The HAMA, HAMD and ATQ scores of both groups lowered more significantly compared with pretreatment （P〈0.01）, so did those（P〈0.05 or 0.01） and such factor score were significantly higher as university, catharsis, interpersonal learning （input）, interpersonal learning （output） and group cohesiveness （P〈0. 001） in research than control group. Conclusion Naikan therapy plus cognitive-behavior group therapy could effectively relieve or eliminate anxious-depressive emotion of inpatients with depression, reduce the frequency of automatic thoughts, and has an advantage in efficacy over single drug treatment.